Jill A. Lindia - Concepedia

Concepedia

Author

Jill A. Lindia

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

J.A. Lindia, Jill A. Lindia, Jill Ann Lindia

17

Publications

3.2K

Citations

10

H-Index

29

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)University of California, San Francisco University of Pittsburgh Angeles Clinic and Research Institute South Texas Accelerated Research Therapeutics

JA

About

Jill A. Lindia is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, immunology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	374
2	Immunology	3	3	322
3	Neuroscience	2	2	228
4	Health Sciences	1	1	199
5	Social Sciences	1	1	29

Jill A. Lindia

×

10

Publications

3.2K

Citations

10

H-Index

	Year	Citations
Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma Antoni Ribas, Omid Hamid, Adil Daud, JAMA	2016	1K
Phase I Study of Pembrolizumab (MK-3475; Anti–PD-1 Monoclonal Antibody) in Patients with Advanced Solid Tumors Amita Patnaik, Soonmo Peter Kang, Drew Rasco, Clinical Cancer Research	2015	767
Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2 Catherine Abbadie, Jill A. Lindia, Anne Marie Cumiskey, Proceedings of the National Academy of Sciences	2003	585
Contribution of the tetrodotoxin-resistant voltage-gated sodium channel Na <sub>V</sub> 1.9 to sensory transmission and nociceptive behavior Birgit T. Priest, Beth Murphy, Jill A. Lindia, Proceedings of the National Academy of Sciences	2005	266
Induction of CX3CL1 Expression in Astrocytes and CX3CR1 in Microglia in the Spinal Cord of a Rat Model of Neuropathic Pain Jill A. Lindia, Erin McGowan, Nina Jochnowitz, Journal of Pain NeuroinflammationInflammationSpinal Cord InjuryHealth SciencesPain Medicine	2005	199
Relationship between sodium channel NaV1.3 expression and neuropathic pain behavior in rats Jill A. Lindia, Martin Köhler, William J. Martin, Pain	2005	188
Long-term efficacy of pembrolizumab (pembro; MK-3475) in a pooled analysis of 655 patients (pts) with advanced melanoma (MEL) enrolled in KEYNOTE-001. Adil Daud, Antoni Ribas, Caroline Robert, Journal of Clinical Oncology Long-term EfficacyImmunologyPharmacotherapyImmunotherapeuticsDermatology	2015	89
P0116 Updated clinical efficacy of the anti-PD-1 monoclonal antibody pembrolizumab (MK-3475) in 411 patients with melanoma Antoni Ribas, Jedd D. Wolchok, Caroline Robert, European Journal of Cancer MedicineMelanomaImmunologyImmune Checkpoint InhibitorImmunotherapy	2015	34
Distribution of the voltage gated sodium channel Nav1.3-like immunoreactivity in the adult rat central nervous system Jill A. Lindia, Catherine Abbadie Brain Research Hyperpolarization (Biology)NeurophysiologySodium HomeostasisPhysiologyIon Channels	2003	29
Pembrolizumab (Pembro; Mk-3475) for Advanced Melanoma (Mel): Randomized Comparison of Two Dosing Schedules Caroline Robert, Anthony M. Joshua, Jeffrey S. Weber, Annals of Oncology MedicineMelanomaImmune Checkpoint InhibitorDermatologyCancer Treatment	2014	23

Page 1